Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA404 Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
NCT01057342Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jan 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vadimezan in small cell lung cancer (SCLC), sponsored by Swiss Group for Clinical Cancer Research. Started Jan 2010; status: completed.
02
Drugs
vadimezan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT01057342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057342.